0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query mrrpb5 global lysosomal storage diseases market size status forecast 2025.Your search for "" gave back 1533058 results.
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update...
Catalog:
Global Markets Direct
November 2022
Price: USD 2,000.00
Cathepsin L1 - Pipeline Review, H2 2020 Summary Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15) - Cathepsin L, a...
Catalog:
Global Markets Direct
October 2020
Price: USD 3,500.00
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022...
Catalog:
Global Markets Direct
November 2022
Price: USD 2,000.00
AAV is transformed from a naturally occurring virus into a delivery mechanism for gene therapy. The viral DNA is replaced with new DNA, and it...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Fabry disease is a rare X-linked lysosomal storage disorder with a deficiency of alpha galactosidase enzyme resulting in progressive organ...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Cathepsin S - Pipeline Review, H2 2020 Summary According to the recently published report 'Cathepsin S - Pipeline Review, H2 2020';...
Catalog:
Global Markets Direct
October 2020
Price: USD 3,500.00
Cathepsin L1 - Pipeline Review, H1 2020 Summary Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15) - Cathepsin L, a...
Catalog:
Global Markets Direct
April 2020
Price: USD 3,500.00
Fabry disease is a rare X-linked lysosomal storage disorder with a deficiency of alpha galactosidase enzyme resulting in progressive organ...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA...
Catalog:
Global Markets Direct
August 2022
Price: USD 3,500.00
AAV is transformed from a naturally occurring virus into a delivery mechanism for gene therapy. The viral DNA is replaced with new DNA, and it...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Proprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neural Apoptosis Regulated Convertase 1 or Subtilisin/Kexin Like Protease...
Catalog:
Global Markets Direct
April 2018
Price: USD 3,500.00
In particular, molecular glue degraders are monovalent compounds that orchestrate interactions between a target protein and an E3 ubiquitin ligase,...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
Mucopolysaccharidosis consists of a group of more than 40 genetic disorders that forms a part of lysosomal storage disease. They are caused by an...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
The global β-Glucuronidase Enzymes market size was valued at US$ million in 2023. With growing demand in downstream market, the β-Glucuronidase...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Fabry Disease - Pipeline Review, H2 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fabry...
Catalog:
Global Markets Direct
August 2020
Price: USD 2,000.00
